Westmount Partners, LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 2051491 LOS ANGELES, CA

Position in ALNY

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$301,030

-$29,840 QoQ

Shares Held

1,000

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#542

of 784 holders

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Westmount Partners, LLC holds $2,556,295 across 6 Biotechnology names. ALNY ranks #3 (11.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	12,961	$1,027,677
2	NTHI	Neonc Technologies Holdings, Inc.	197,178	$893,216
3	ALNY	Alnylam Pharmaceuticals, Inc. This page	1,000	$301,030
4	BBIO	BridgeBio Pharma, Inc.	3,118	$232,228
5	ALLO	Allogene Therapeutics, Inc.	36,000	$74,880
6	FATE	Fate Therapeutics Inc	10,098	$27,264

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$301,030	1,000	0.0%	Shares	Sole	2026-07-07
2026-03-31	$330,870	1,000	0.0%	Shares	Sole	2026-04-16
2025-12-31	$397,650	1,000	0.0%	Shares	Sole	2026-01-15
2025-09-30	$456,000	1,000	0.0%	Shares	Sole	2025-10-14
2025-06-30	$326,090	1,000	0.0%	Shares	Sole	2025-07-09
2025-03-31	$270,020	1,000	0.0%	Shares	Sole	2025-05-01
2024-12-31	$235,310	1,000	0.0%	Shares	Sole	2025-01-13
2024-09-30	$275,030	1,000	-0.5%	Shares	Sole	2025-01-13
2024-06-30	$244,215	1,005	+0.5%	Shares	Sole	2025-01-28
2023-03-31	$200,320	1,000	0.0%	Shares	Sole	2025-01-29
2022-12-31	$237,650	1,000	—	Shares	Sole	2025-01-28
No filing history on record for this holder in this stock.